Evogene Ltd. (EVGN)
0.5076
-0.03
(-5.63%)
USD |
NASDAQ |
Sep 08, 16:00
0.5002
-0.01
(-1.46%)
After-Hours: 20:00
Evogene Enterprise Value : 8.679M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 8.679M |
| September 04, 2026 | 9.089M |
| September 03, 2026 | 9.185M |
| September 02, 2026 | 9.109M |
| September 01, 2026 | 8.857M |
| August 31, 2026 | 9.07M |
| August 28, 2026 | 9.247M |
| August 27, 2026 | 9.090M |
| August 26, 2026 | 9.158M |
| August 25, 2026 | 9.246M |
| August 24, 2026 | 9.374M |
| August 21, 2026 | 9.422M |
| August 20, 2026 | 9.395M |
| August 19, 2026 | 9.942M |
| August 18, 2026 | 9.694M |
| August 17, 2026 | 9.388M |
| August 14, 2026 | 9.940M |
| August 13, 2026 | 10.62M |
| August 12, 2026 | 10.09M |
| August 11, 2026 | 11.29M |
| August 10, 2026 | 10.37M |
| August 07, 2026 | 9.931M |
| August 06, 2026 | 11.08M |
| August 05, 2026 | 10.35M |
| August 04, 2026 | 10.61M |
| Date | Value |
|---|---|
| August 03, 2026 | 9.063M |
| July 31, 2026 | 8.183M |
| July 30, 2026 | 8.432M |
| July 29, 2026 | 8.328M |
| July 28, 2026 | 8.502M |
| July 27, 2026 | 8.847M |
| July 24, 2026 | 9.151M |
| July 23, 2026 | 9.154M |
| July 22, 2026 | 9.177M |
| July 21, 2026 | 9.010M |
| July 20, 2026 | 9.245M |
| July 17, 2026 | 10.32M |
| July 16, 2026 | 9.724M |
| July 15, 2026 | 9.652M |
| July 14, 2026 | 8.347M |
| July 13, 2026 | 8.098M |
| July 10, 2026 | 8.738M |
| July 09, 2026 | 8.576M |
| July 08, 2026 | 7.413M |
| July 07, 2026 | 7.558M |
| July 06, 2026 | 7.741M |
| July 02, 2026 | 7.624M |
| July 01, 2026 | 7.777M |
| June 30, 2026 | 7.749M |
| June 29, 2026 | 3.972M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Compugen Ltd. | 120.22M |
| Pluri, Inc. | 42.93M |
| Scinai Immunotherapeutics Ltd. | 7.323M |
| CollPlant Biotechnologies Ltd. | 49.66M |
| Regentis Biomaterials Ltd. | 52.93M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.591M |
| Revenue (Quarterly) | 0.347M |
| Total Expenses (Quarterly) | 1.939M |
| EPS Diluted (Quarterly) | -0.1449 |
| Gross Profit Margin (Quarterly) | -2.31% |
| Profit Margin (Quarterly) | -458.5% |
| Earnings Yield | -179.7% |
| Normalized Earnings Yield | -179.71 |